General Information:
Id: | 1,068 |
Diseases: |
Alzheimer disease
- [OMIM]
|
Mus musculus | |
BTO:0003037 HT-22 cell | |
article | |
Reference: | Sun KH et al.(2008) Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction J. Neurochem. 107: 265-278 [PMID: 18691386] |
Interaction Information:
Comment | Peroxiredoxin-I (Prx-I) and peroxiredoxin-II (Prx-II) were identified as direct substrates of Cdk5 from mouse brain lysates. |
Formal Description Interaction-ID: 6726 |
|
Drugbank entries | Show/Hide entries for CDK5 |
Comment | Peroxiredoxin-I (Prx-I) and peroxiredoxin-II (Prx-II) were identified as direct substrates of Cdk5 from mouse brain lysates. |
Formal Description Interaction-ID: 6732 |
|
Drugbank entries | Show/Hide entries for CDK5 or PRDX2 |
Comment | Prx-I and Prx-II lose their peroxidase functions upon phosphorylation by Cdk5/p25. |
Formal Description Interaction-ID: 6737 |
|
Drugbank entries | Show/Hide entries for CDK5 |
Comment | Prx-I and Prx-II lose their peroxidase functions upon phosphorylation by Cdk5/p25. |
Formal Description Interaction-ID: 6738 |
|
Drugbank entries | Show/Hide entries for PRDX2 |
Comment | Prx-I and Prx-II lose their peroxidase functions upon phosphorylation by Cdk5/p25. |
Formal Description Interaction-ID: 6784 |
|
Drugbank entries | Show/Hide entries for PRDX2 |
Comment | Prx-I and Prx-II lose their peroxidase functions upon phosphorylation by Cdk5/p25. |
Formal Description Interaction-ID: 6785 |
|
Comment | Prx-I and Prx-II lose their peroxidase functions upon phosphorylation by Cdk5/p25. |
Formal Description Interaction-ID: 6786 |
|
Comment | Cdk5 is a key enzyme that promotes ROS accumulation upon glutamate stimulation. Inhibition of Cdk5 leads to reduction of ROS accumulation in primary neurons upon Abeta and glutamate stimulation. |
Formal Description Interaction-ID: 6840 |
gene/protein affects_quantity of drug/chemical compound Reactive oxygen species |
Drugbank entries | Show/Hide entries for CDK5 |
Comment | Glutamate stimulation increased ROS levels. |
Formal Description Interaction-ID: 6841 |
drug/chemical compound increases_quantity of drug/chemical compound Reactive oxygen species |
Comment | Abeta(25-35) treatment resulted in more than 2.5-fold increase in ROS levels in primary cortical cells, which was Cdk5-dependent. |
Formal Description Interaction-ID: 6843 |
gene/protein increases_quantity of drug/chemical compound Reactive oxygen species |
Comment | Cdk5 initiates oxidative stress and thus may be an upstream regulator of mitochondrial damage. |
Formal Description Interaction-ID: 6844 |
|
Drugbank entries | Show/Hide entries for CDK5 |
Comment | Sole activation of Cdk5 is not enough to cause significant mitochondrial damage. |
Formal Description Interaction-ID: 6845 |
|
Drugbank entries | Show/Hide entries for CDK5 |
Comment | Cdk5 initiates oxidative stress and thus may be an upstream regulator of mitochondrial damage. |
Formal Description Interaction-ID: 20823 |
|
Drugbank entries | Show/Hide entries for CDK5 |